From Terminal to Thriving: Gordon’s Immunotherapy Journey

After exhausting nearly every option for stage 4 colorectal cancer, Gordon Levine found new hope in immunotherapy. Today, he’s cancer-free and advocating for more patients to get the same second chance. You don't have to navigate your journey alone. ❤️ View CRI's free resources for patients and caregivers: https://bit.ly/4sadHgI ⏩ WATCH NEXT How This Sales Exec Talked Her Way Into the Clinical Trial That Saved Her Life:    • How This Sales Exec Talked Her Way Into th...   🔗 ADDITIONAL RESOURCES Read Gordon's full story: https://bit.ly/4l5nYb6 For more information on immunotherapy and colorectal cancer: https://bit.ly/4l67UpB 💙 Your gift today can help renew hope for more patients: https://bit.ly/3NuWH5N #Stage4Cancer #PatientAdvocacy #ClinicalTrials #CRI #ColorectalCancer #CancerResearch #Immunotherapy #CancerSurvivor #CancerTreatment #CancerDiagnosis -- Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. https://www.cancerresearch.org Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.